Patent ID: 6489331
Filing Date: 2002-12-03
Classification: A61K,A61P,C07D,Y10S

Abstract:
A method for therapeutic treatment of diabetes, which comprises administering to a mammal a therapeutically effective amount of a compound represented by the general formula (I), or a physiologically acceptable salt thereof: wherein R1 represents a hydrogen atom, a lower alkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted aromatic heterocyclic group; R2 represents a hydrogen atom, a lower alkyl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted aromatic heterocyclic group; R3 represents a hydrogen atom, a lower alkyl group, or a substituted or unsubstituted aralkyl group; X1 and X2 independently represent a hydrogen atom, a lower alkyl group, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted aryl group; and the symbol â€œnâ€  represents an integer of from 0 to 3.